SAF-Holland SE : The revival in interest should continue
Entry price | Target | Stop-loss | Potential |
---|
€12.11 |
€13.2 |
€11.4 |
+9.05% |
---|
Market participant are once again showing interest in shares in SAF-HOLLAND S.A.. The technical chart pattern now appears positive for the short term with new upside potential.
Summary● The company has solid fundamentals for a short-term investment strategy.
Strengths● The company shows low valuation levels, with an enterprise value at 0.65 times its sales.
● Its low valuation, with P/E ratio at 11.11 and 10.57 for the ongoing fiscal year and 2017 respectively, makes the stock pretty attractive with regard to earnings multiples.
● This company will be of major interest to investors in search of a high dividend stock.
● Analysts covering this company mostly recommend stock overweighting or purchase.
● The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses● Technically, the stock approaches a strong medium-term resistance at EUR 11.56.
● With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
● For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
● For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.